Wealth Advisory Solutions, LLC Eli Lilly & CO Transaction History

Wealth Advisory Solutions, LLC

$363 Million
Q3 2024

A detailed history of Wealth Advisory Solutions, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wealth Advisory Solutions, LLC holds 15,892 shares of LLY stock, worth $11.9 Million. This represents 3.88% of its overall portfolio holdings.

Number of Shares

15,892

Previous 16,386 3.01%

Holding current value

$11.9 Million

Previous $14.8 Million 5.1%

% of portfolio

3.88%

Previous 4.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$772.14 - $960.02 $381,437 - $474,249	-494 Reduced 3.01%	15,892 $14.1 Million
Q2 2024 Jul 26, 2024	SELL	$724.87 - $909.04 $1.16 Million - $1.45 Million	-1,600 Reduced 8.9%	16,386 $14.8 Million
Q1 2024 Apr 23, 2024	SELL	$592.2 - $792.28 $20,727 - $27,729	-35 Reduced 0.19%	17,986 $14 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $157,557 - $185,739	300 Added 1.69%	18,021 $10.5 Million
Q3 2023 Feb 07, 2024	SELL	$434.7 - $599.3 $1.49 Million - $2.05 Million	-3,423 Reduced 16.19%	17,721 $9.52 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $357,053 - $477,421	-1,018 Reduced 4.59%	21,144 $9.92 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $1.36 Million - $1.6 Million	-4,386 Reduced 16.52%	22,162 $7.61 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $638,919 - $744,469	-1,987 Reduced 6.96%	26,548 $9.71 Million
Q3 2022 Nov 16, 2022	SELL	$296.48 - $337.87 $292,922 - $333,815	-988 Reduced 3.35%	28,535 $9.23 Million
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $441,508 - $518,395	1,584 Added 5.67%	29,523 $9.57 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $495,430 - $615,694	-2,111 Reduced 7.02%	27,939 $8 Million
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $52,962 - $65,177	-239 Reduced 0.79%	30,050 $6.94 Million
Q2 2021 Jul 21, 2021	BUY	$180.55 - $233.54 $90,997 - $117,704	504 Added 1.69%	30,289 $6.95 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $5.41 Million - $7 Million	-32,899 Reduced 52.48%	29,785 $6,000
Q4 2020 Jan 28, 2021	BUY	$130.46 - $172.63 $34,441 - $45,574	264 Added 0.42%	62,684 $10.5 Million
Q3 2020 Dec 29, 2020	BUY	$146.22 - $169.13 $3.46 Million - $4.01 Million	23,695 Added 61.19%	62,420 $9.24 Million
Q2 2020 Dec 23, 2020	SELL	$136.42 - $164.18 $33,695 - $40,552	-247 Reduced 0.63%	38,725 $6.36 Million
Q1 2020 Dec 18, 2020	SELL	$119.05 - $147.35 $911,089 - $1.13 Million	-7,653 Reduced 16.41%	38,972 $5.41 Million
Q4 2019 Jan 27, 2021	BUY	$106.92 - $132.43 $4.99 Million - $6.17 Million	46,625 New	46,625 $6.13 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Advisory Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Advisory Solutions, LLC with notifications on news.

Account

Wealth Advisory Solutions, LLC Eli Lilly & CO Transaction History